← Open Payments lookup

GWENDOLYN DANIEL: Open Payments

NPI 1225789019 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$569 in 11 payments from 5 companies in 2025. Trend: 2023 $640 · 2024 $102 · 2025 $569

Food & beverage: $569
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$187
SK Life Science, Inc.2$140
Neurocrine BioSciences, Inc.2$138
ACADIA Pharmaceuticals Inc1$63
Alpha Cognition USA, Inc.1$40

Products named: REXULTI, INGREZZA, XCOPRI, NUPLAZID, Zunveyl.

Industry payments across TX — which companies pay providers there.